Pierlorenzo Pallante

Naples, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications

Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience.

Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience.

Journal: The journal of liquid biopsy
Published: July 04, 2025

Harmonization trial of FGFR1-3 testing strategies in cholangiocarcinoma patients: an Italian multicenter experience.

Harmonization trial of FGFR1-3 testing strategies in cholangiocarcinoma patients: an Italian multicenter experience.

Journal: Pathologica
Published: May 13, 2025

The Interconnection Between UbcH10, p53, and EGFR in Lung Cancer Cells and Their Involvement in Treatment Response.

The Interconnection Between UbcH10, p53, and EGFR in Lung Cancer Cells and Their Involvement in Treatment Response.

Journal: Genes
Published: January 29, 2025

Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer.

Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer.

Journal: Translational cancer research
Published: December 16, 2024

Identification of a prognostic DNA repair gene signature in esophageal cancer.

Identification of a prognostic DNA repair gene signature in esophageal cancer.

Journal: Journal of gastrointestinal oncology
Published: April 11, 2024

Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma.

Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma.

Journal: Cell cycle (Georgetown, Tex.)
Published: January 02, 2024

Development and validation of a prognostic model based on RNA binding proteins in patients with esophageal cancer.

Development and validation of a prognostic model based on RNA binding proteins in patients with esophageal cancer.

Journal: Journal of thoracic disease
Published: August 21, 2023

Differential Expression of LncRNA in Bladder Cancer Development.

Differential Expression of LncRNA in Bladder Cancer Development.

Journal: Diagnostics (Basel, Switzerland)
Published: April 19, 2023

The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness.

The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness.

Journal: Cell death discovery
Published: March 28, 2023

Correction: Sepe et al. The Long Non-Coding RNA RP5-1024C24.1 and Its Associated-Gene MPPED2 Are Down-Regulated in Human Thyroid Neoplasias and Act as Tumour Suppressors. Cancers 2018, 10, 146.

Correction: Sepe et al. The Long Non-Coding RNA RP5-1024C24.1 and Its Associated-Gene MPPED2 Are Down-Regulated in Human Thyroid Neoplasias and Act as Tumour Suppressors. Cancers 2018, 10, 146.

Journal: Cancers
Published: December 05, 2022

Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells.

Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells.

Journal: Oncotarget
Published: May 31, 2022

Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas.

Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas.

Journal: Cancers
Published: April 21, 2022
Showing 1-12 of 68

Last Updated: 09/26/2026